rethinkPeptides Search
Menu
Research citation

Dual Glucagon-Like Peptide-1 (GLP-1) and Glucose-Dependent Insulinotropic Polypeptide (GIP) Receptor Agonist-Associated Thyroiditis: A Case Report of Thyroid Dysfunction Following Tirzepatide Use.

evidence

This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.

Read the original research

Dual Glucagon-Like Peptide-1 (GLP-1) and Glucose-Dependent Insulinotropic Polypeptide (GIP) Receptor Agonist-Associated Thyroiditis: A Case Report of Thyroid Dysfunction Following Tirzepatide Use.

Cureus, 17(5), e85123

Citation

Humaida, Sara; Manzalji, Kamar; Seyam, Naheel; Al-Masalmani, Lolwa. (2025). Dual Glucagon-Like Peptide-1 (GLP-1) and Glucose-Dependent Insulinotropic Polypeptide (GIP) Receptor Agonist-Associated Thyroiditis: A Case Report of Thyroid Dysfunction Following Tirzepatide Use.. Cureus, 17(5), e85123. https://doi.org/10.7759/cureus.85123